
SenesTech, Inc.

News
With the recent EPA approval (http://nnw.fm/X82tJ) of SenesTech's (NASDAQ:SNES) ContraPest(R), a humane, liquid contraceptive bait designed to address unwieldy rodent populations, there now appears to be an impending end to the unsustainable rodenticide paradigm that has persisted for decades due to a lack of other options. SenesTech is Arizona's newest public company, as of its December 8 IPO (http://nnw.fm/m4xhG) on the NASDAQ Capital Market. The publicly traded stock gives investors a big opportunity to get in on the ground floor behind a proprietary and potentially paradigm-shattering technology that is not only safe to humans, but also drastically less impactful to the environment.
696 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 6) (Last 30 Days: 18) (Since Published: 696)